Jacob Robins is currently a Senior Scientist at AstraZeneca, specializing in oncology since 2024. Previously, Jacob served as a Postdoctoral Associate at Yale University from 2022 to 2024, collaborating with the NSF Center for Genetically Encoded Materials and focusing on peptide and small molecule synthesis. Jacob earned a Ph.D. in Organic Chemistry from the University of North Carolina at Chapel Hill, where they made significant progress in the total synthesis of complex compounds. Additionally, Jacob held the position of Chairperson at STEM Pride of the Triangle from 2018 to 2021 and conducted undergraduate research at William & Mary, culminating in notable syntheses of bioactive compounds.
This person is not in the org chart
This person is not in any teams
This person is not in any offices